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Developmental Expression of PDGF, TGF-a, and
TGF-j Genes in Preimplantation Mouse Embryos
DANIEL A. RAPPOLEE,* CAROL A. BRENNER, RICHARD SCHULTZ,t
DAVID MARK, ZENA WERB
Control of growth and differentiation during mammalian embryogenesis may be
regulated by growth factors from embryonic or maternal sources. With the use of
single-cell messenger RNA phenotyping, the simultaneous expression of growth factor
transcripts in single or small numbers of preimplantation mouse embryos was
examined. Transcripts for platelet-derived growth factor A chain (PDGF-A), transforming growth factor (TGF)-a, and TGF- 1, but not for four other growth factors,
were found in whole blastocysts. TGF-cx, TGF-(31, and PDGF antigens were detected
in blastocysts by immunocytochemistry. Both PDGF-A and TGF-a were detected as
maternal transcripts in the unferilized ovulated oocyte, and again in blastocysts. TGFP1 transcripts appeared only after fertilization. The expression of a subset of growth
factors in mouse blastocysts suggests a role for these factors in the growth and
differentiation of early mammalian embryos.
B

ECAUSE PREIMPLANTATION MOUSE

embryos grow and differentiate in
the absence of exogenous factors,
endogenous factors must sustain the embryo
during the first seven to eight cleavage divisions (1). Indirect evidence indicates that
preimplantation embryos may make growth
factors. Cultured embryos from around the
time of implantation produce transforming
growth factor-like bioactivity that promotes
anchorage-independent growth (2). Teratocarcinoma cells, which are thought to be
similar to primitive ectoderm, produce
PDGF (3), insulin-like growth factor-II
(IGF-II) (4), and three stem cell growth
factors (5). After implantation in the uterus,
mouse embryos produce the fibroblast
growth factor homolog int-2, TGF-a, TGF3 (6), and IGF-ll (4), but the presence of
these growth factors cannot be extrapolated
to the preimplantation embryo. Direct evidence for growth factor transcripts of low

copy number has been impossible to obtain
in preimplantation embryos, because thousands of embryos are required to detect even
high copy number transcripts such as histone or actin by RNA blot analysis (7).
We recently developed a sensitive and
quantitative method for assaying the accu-

mulation of mRNA transcripts in small
numbers of cells. Our procedure, single-cell
RNA phenotyping (8), can detect mRNA in
a single cell and in '10 RNA transcripts,
and resolves threefold differences in input
over two orders of magnitude. Thus, this
method overcomes the difficulties inherent
in the analysis of growth factor transcripts in
early embryos. It consists of a microtechnique for isolation of total RNA from 1 to
100 mouse embryos, coupled with two enzymatic steps (9): reverse transcription (RT)
and amplification of the transcribed cDNA
in a polymerase chain reaction (PCR) (10).
The positions of the target sequences for the
transcripts are shown in Table 1. Fragments
were selected for inclusion of restriction
sites, identification by existing cDNA clones
by DNA blot analysis, and/or inclusion of
introns that would generate longer fragments if DNA or unprocessed RNA contaminated the reaction. When mouse cDNA
sequences were not available, oligonucleotide sequences from other species were chosen to cover areas of conserved sequence
with nondegenerate amino acids on the 3'
inside ends.
We detected 3-actin RNA transcripts isolated from a single mouse blastocyst by RTPCR; the signal became stronger when the
number of PCR cycles was increased from
30 to 60 (11). We then used RT-PCR to
detect growth factor transcripts in blastocysts and determined the growth factor
mRNA phenotype of the blastocysts. Three
growth factor genes, TGF-a, TGF-(1, and
PDGF-A, were expressed in mouse blastocysts (Fig. 1A). The blastocysts were uncultured; thus expression was not induced by
prolonged handling of embryos. The cDNA
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Fig. 1. Detection of mRNA transcripts in mouse blastocysts by RT-PCR. (A) Expression of three
growth factor transcripts in mouse blastocysts demonstrated by agarose gel electrophoresis of the RTPCR amplified reaction products obtained after 60 cydes of PCR. The PCR reaction mixtures for the
blastocysts (B) contained cDNA from the RNA of 2.2 embryo equivalents in each reaction, and the
PCR reaction mixtures for the positive controls (+) contained cDNA from 10 ng of total RNA (9). The
molecular size markers (M) are Hae IIl-digested 4X174 replicative form DNA. (B) Restriction enzyme
D. A. Rappolee, C. A. Brenner, R. Schultz, Z. Werb, analysis of cDNA fragments generated by RT-PCR. Messenger RNA transcripts were expressed by
Laboratory of Radiobiology and Environmental Health blastocysts incubated with the enzymes indicated in Table 1. The diagnostic fagments (arrowheads) are
and Department of Anatomy, University of California,
TGF-a, 159 bp; TGF-,B1, 119 + 125 bp; ,-actin, 151 bp; and PDGF-A, 129 bp. (C) Lack of
San Francisco, CA 94143-0750.
D. Mark, Department of Molecular Biology, Cetus Cor- expression offour growth factors in mouse blastocysts demonstrated by agarose gel electrophoresis of
the RT-PCR amplified reaction products obtained after 60 cydes of PCR. The PCR reaction nixtr
poration, Emeryville, CA 94608.
for blastocysts (B) contained cDNA from the mRNA of 2.2 embryo equivalents in each reaction, and
the PCR reaction mixtures for the positive controls (+) contained cDNA from 10 to 100 ng of total
*To whom all correspondence should be addressed.
tPresent address: Department of Biology, University of RNA. The threshold for detection of the growth factors is generally <1 to 100 pg of total RNA; for
Pennsylvania, Philadclphia, PA 19104.
NGF, as few as ten RNA molecules can be detected by RT-PCR (8).
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Escherichia coli strain in which the synthesis of IL-3
was driven by the bacteriophage A pL promoter.
The intercellularly expressed IL-3 was purified to
homogeneity by reversed-phase high-performance
liquid chromatography in the presence of urea and
dithiothreitol. The biologically active protein was
produced by dilution of the denaturant, addition of
oxidized glutathione, and dialysis against decreasing
concentrations of urea. The purified IL-3 was formulated in physiological saline, and the final preparation had less than 1 U of endotoxin per milligram
as measured by the Limulus amoebocyte lysate assay
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Location oligonucleotides
nucleotide sequence
Transcriptim
of

Amplified fragmnent
Predicted
size (bp)

,B-Actin, mouse
TGF-a, rat
TGF-11, mouse
PDGF-A, human
EGF, mouse
bFGF, bovine
NGF-,, mouse
G-CSF, mouse
Stromelysin, rabbit

240
239
244
224
350
282
422
294
212

Restriction
site

5' Oligonucleotide

3' Oligonucleotide

Bgl II

25-44
58-78
1277-1296
622-645
3953-3972
295-321
248-267
490-517
1278-1297

269-245
297-277
1521-1502
848-826
4200-4181
578-554
649-630
705-681
1480-1461

Sph I
Sma I
Acc I
Pst I
Bam HI
Nco I
Pvu II
Nco I

blastulation stage in Xenopus (17, 19). However, early development of the mouse has
several properties that distinguish it from
that of the frog. First, the mouse egg is
small, has little yolk, and quickly activates its
zygotic transcription after fertilization (12).
Second, the mouse has 10- to 12-hour cell
cycle times after the first two cell cycles (20).
These cycles have the normal G1-S-G2-M
periods, which may allow early transcription
of growth factors, as well as the opportunity
to be influenced by growth factors, in contrast to the early cell cycles of the frog,
which lack GI and G2 (21).
Several lines of evidence indicate that
mammalian embryonic factors are directed
at maternal tissue. TGF-a and TGF-P are
known to be angiogenic (22), and the highest density of uterine capillary beds is opposite the implanting blastocyst (23). In addition, the uterine environment is hypoxic
(24), a condition that promotes production
of angiogenic factors by wound healing cells
(25). Finally, TGF-a is an EGF receptorbinding ligand, and at the time of implantation there is a surge of estrogen that increases EGF-receptor expression in the uterus severalfold (26). Thus, embryonic growth
factors may induce the early angiogenesis
and decidualization of the uterus. Whether
embryonic growth factors are directed at
intraembryonic targets will be determined
only when it is demonstrated that genes for
embryonic growth factor receptors are transcribed and translated and that these receptors are functional.

Cold Spring Harbor, NY, 1985), pp. 393-399.
6. A. Jakobovits et al., Proc. Natl. Acad. Sci. U.S.A. 83,
7806 (1986); D. R. Twardzik, Cancer Res. 45, 5413
(1985); U. I. Heine et al., J. Cell Biol. 105, 2861

(1987).
7. D. H. Giebelhaus, J. J. Heikkila, G. A. Schultz, Dev.
Biol. 98, 148 (1983).
8. D. A. Rappolee, D. Mark, M. J. Banda, Z. Werb,
Science 241, 708 (1988); D. A. Rappolee, A. Wang,
D. Mark, Z. Werb, J. Cell. Biochem., in press.
9. Standard techniques [B. Hogan, F. Costantini, E.
Lacy, Eds., Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold

Spring Harbor, NY, 1986), pp. 89-149)] were used
for obtaining eggs and zygotes from female CF-I
mice (25 to 30 g, Harlan Sprague-Dawley) mated
overnight with stud F1 hybrid males (from
C57BL/6J females x SJLJJ males, Jackson Laboratory). All embryonic ages are expressed as days of
gestation (d.g.), with noon ofthe plug day designated as 0.5 d.g. Ovulated unfertilized oocytes were
dissected from oviducts and freed from adherent
cumulus cells, deavage-stage embryos were flushed
from the oviducts at 2.3 d.g., and blastocysts were
flushed from the uteri at 3.5 d.g., washed extensively, and checked under a dissecting microscope to
ensure that there was no somatic cell contamination.
A microadaptation (8) of the GuSCN/CsCl procedure [N. J. Chirgwin, A. E. Pryzybyla, R. J. MacDonald, W. J. Rutter, Biochemistry 18, 5294 (1979)]
was used to prepare total RNA from embryos. One
to several hundred eggs or embryos were washed
through six drops of L-15 medium and added to
100 01 of GuSCN solution containing 20 ±g Escherichi coli ribosomal RNA as carrier, and RNA was
purified by centrifugation (8). Yields of RNA were
generally 35 to 50%. Total RNA used for positive
controls was prepared from the following sources:
bFGF and TGF-ca, from mouse brain; NGF-,, from
Balb/c 3T3 fibroblasts; TGF-,B1, ,-actin, G-CSF,
and PDGF-A, from lipopolysaccharide-stimulated
mouse macrophages; and EGF, from mouse submaxillary gland. RNA was reverse transcribed with
Moloney murine leukemia virus (MMLV) reverse
transcriptase (BRL) with oligo(dT) priming (8).
Reverse transcription was repeated by denaturing at
93°C, flash cooling on ice, and reincubating with an
additional 50 U of enzyme. PCR was performed
essentially as previously described (8, 10). Experiments were performed at least two tines with
indepcndent embryo preparations.
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Table 1. Oligonucleotide primers used for RNA phenotyping analysis. Sequences are from published
sources (27).

